CL2004000856A1 - Compuestos derivados 8b-vonil-11b-(alfa-sustituidos)alquil-estra-1,3,5(10)-trienos; composiciones farmaceuticas; compuestos intermediarios; uso para la anticoncepcion, para el tratamiento de carcinomas de ovario y tumores de celulas granulosas. - Google Patents

Compuestos derivados 8b-vonil-11b-(alfa-sustituidos)alquil-estra-1,3,5(10)-trienos; composiciones farmaceuticas; compuestos intermediarios; uso para la anticoncepcion, para el tratamiento de carcinomas de ovario y tumores de celulas granulosas.

Info

Publication number
CL2004000856A1
CL2004000856A1 CL200400856A CL2004000856A CL2004000856A1 CL 2004000856 A1 CL2004000856 A1 CL 2004000856A1 CL 200400856 A CL200400856 A CL 200400856A CL 2004000856 A CL2004000856 A CL 2004000856A CL 2004000856 A1 CL2004000856 A1 CL 2004000856A1
Authority
CL
Chile
Prior art keywords
compounds
vonil
trienos
alquil
estra
Prior art date
Application number
CL200400856A
Other languages
English (en)
Inventor
Brauer Olaf Peters Alexan Nico
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CL2004000856A1 publication Critical patent/CL2004000856A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CL200400856A 2003-04-22 2004-04-22 Compuestos derivados 8b-vonil-11b-(alfa-sustituidos)alquil-estra-1,3,5(10)-trienos; composiciones farmaceuticas; compuestos intermediarios; uso para la anticoncepcion, para el tratamiento de carcinomas de ovario y tumores de celulas granulosas. CL2004000856A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10318896A DE10318896A1 (de) 2003-04-22 2003-04-22 8beta-Vinyl-11beta-(omega-substituierte)alkyl-estra-1,3,5(10)-triene

Publications (1)

Publication Number Publication Date
CL2004000856A1 true CL2004000856A1 (es) 2005-03-28

Family

ID=33304956

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400856A CL2004000856A1 (es) 2003-04-22 2004-04-22 Compuestos derivados 8b-vonil-11b-(alfa-sustituidos)alquil-estra-1,3,5(10)-trienos; composiciones farmaceuticas; compuestos intermediarios; uso para la anticoncepcion, para el tratamiento de carcinomas de ovario y tumores de celulas granulosas.

Country Status (21)

Country Link
US (1) US7375098B2 (es)
EP (1) EP1622924A2 (es)
JP (1) JP2006524202A (es)
KR (1) KR20060005386A (es)
CN (1) CN100381457C (es)
AR (1) AR044056A1 (es)
AU (1) AU2004232462A1 (es)
BR (1) BRPI0409794A (es)
CA (1) CA2522354A1 (es)
CL (1) CL2004000856A1 (es)
CR (1) CR8053A (es)
DE (1) DE10318896A1 (es)
EA (1) EA009606B1 (es)
EC (1) ECSP056180A (es)
MX (1) MXPA05011386A (es)
NO (1) NO20055493L (es)
PE (1) PE20050423A1 (es)
RS (1) RS20050793A (es)
UY (1) UY28284A1 (es)
WO (1) WO2004094451A2 (es)
ZA (1) ZA200509447B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK14632002A3 (sk) * 2000-04-12 2003-03-04 Schering Aktiengesellschaft Substituované estratriény a ich použitie ako selektívne účinných estrogénov
BRPI0514974A (pt) 2004-09-07 2008-07-01 Wyeth Corp composto, composição, métodos de tratar ou inibir uma doença ou condição, estados de doença induzidos por radical livre em um mamìfero, dano à junta secundário aos procedimentos artroscópicos ou cirúrgicos em um mamìfero, infertilidade em um mamìfero, de diminuir os nìveis de colesterol, triglicerìdeos, lp(a), ou ldl, de fornecer realce na cognição ou neuroproteção, de contracepção em um mamìfero, e para preparar um composto, e, produto
MX2007006653A (es) * 2005-10-05 2009-02-17 Sicor Inc Separacion de isomeros de fulvestrant.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1226155B1 (de) * 1999-11-02 2007-05-02 Bayer Schering Pharma AG 18-nor-steroide als selektiv wirksame estrogene
SK14632002A3 (sk) * 2000-04-12 2003-03-04 Schering Aktiengesellschaft Substituované estratriény a ich použitie ako selektívne účinných estrogénov
DE10151114A1 (de) * 2001-10-15 2003-04-17 Schering Ag 8ß-Substituierte-11ß-aryl-estra-2,3,5(10)-trienderivate

Also Published As

Publication number Publication date
NO20055493L (no) 2006-01-18
EP1622924A2 (de) 2006-02-08
EA200501568A1 (ru) 2006-06-30
BRPI0409794A (pt) 2006-05-30
WO2004094451A2 (de) 2004-11-04
PE20050423A1 (es) 2005-08-13
EA009606B1 (ru) 2008-02-28
MXPA05011386A (es) 2006-04-18
ZA200509447B (en) 2009-08-26
JP2006524202A (ja) 2006-10-26
CA2522354A1 (en) 2004-11-04
KR20060005386A (ko) 2006-01-17
US7375098B2 (en) 2008-05-20
CN1777618A (zh) 2006-05-24
AR044056A1 (es) 2005-08-24
WO2004094451A3 (de) 2004-12-23
US20050065135A1 (en) 2005-03-24
AU2004232462A1 (en) 2004-11-04
CN100381457C (zh) 2008-04-16
NO20055493D0 (no) 2005-11-21
ECSP056180A (es) 2006-04-19
DE10318896A1 (de) 2004-11-25
CR8053A (es) 2006-05-29
RS20050793A (sr) 2008-04-04
UY28284A1 (es) 2004-11-30

Similar Documents

Publication Publication Date Title
CL2004001069A1 (es) Compuestos derivados de 1-benzoil-isoquinolinas sustituidos; procedimiento de preparacion, composicion farmaceutica; y uso para el tratamiento o profilaxis de diabetes tipo ii.
NO2014009I2 (no) Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
CL2004000889A1 (es) COMPUESTOS DERIVADOS DE PIRAZOLO[4,3-d]PIRIMIDINA; COMPUESTOS INTERMEDIARIOS; COMPOSICION FARMACEUTICA; PROCEDIMIENTO DE PREPARACION Y SU USO EN LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA HIPERTENSION.
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
SV2004001432A (es) 2-tio-3,5-diciano-4-4fenil-6-aminopiridinas substituidas y su uso ref. lea 35 640-sv
WO2003095455A3 (en) Substituted pyrazolopyrimidines
CL2004000930A1 (es) Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos.
PA8571001A1 (es) 2-(2,6-diclorofenil)-diarilimidazoles
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
BR0307351A (pt) Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
IS6658A (is) Ný efnasambönd
EP2332904A3 (en) Derivatives of tetracycline compounds
ATE302782T1 (de) Substituierte 1-oxa-2,8-diaza-spiro(4,5)dec-2-en- derivate als arzneimittel gegen schmerz
ES1053304Y (es) Disposicion mejorada para la fijacion de fregaderos.
NO20054787L (no) Indenderivater som farmasotiske midler
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
BR0314241B1 (pt) composto, processos para a preparaÇço do mesmo e para a carbonilaÇço de um composto etilenicamente insaturado, composiÇço, e, uso de um composto ou de uma composiÇço.
NO20052866L (no) Imidazokinolinderivater som adenosin A3 reseptorligander
TR199901017A2 (xx) B�cek ilac� terkibi.
BR0207102A (pt) Forma cristalina, composição farmacêutica, uso de uma forma cristalina, e, método para a prevenção ou o tratamento de doença
ITRM20030194A0 (it) Uso di derivati del 7-nitro-2,1,3-benzossadiazolo per la terapia di forme tumorali.
DK2042182T3 (da) Farmaceutisk sammensætning, der omfatter arsen, til behandling af malignitet.
SE0302755D0 (sv) Novel compounds